ABSTRACT Monoclonal antibody directed against the transformation-related protein p53 was microinjected manually into the nuclei of quiescent Swiss 3T3 mouse cells. The cells were subsequently stimulated with 10% fetal calf serum. Microinjection of p53 antibody at or around the time of serum stimulation clearly inhibited the subsequent entry of Swiss 3T3 cells into the S phase of the cell cycle. p53 antibody had no effect on serum-stimulated DNA synthesis when it was microinjected 4 hr or later after serum stimulation. Monoclonal antibody to an unrelated antigen, Lyt-2.2, had no effect on serum-stimulated DNA synthesis regardless of the-time it was microinjected. Under similar experimental conditions, p53 antibody had no effect on simian virus 40-or adenovirus 2-induced DNA synthesis. These experiments add strength to the suggestion that p53 is involved in the regulation of cell proliferation.
A protein with a molecular weight ofapproximately 53,000 (p53) has been identified in mouse cells transformed by viruses, chemicals, orx-radiation (1) (2) (3) (4) (5) (6) . This protein, although in smaller amounts, has also been detected in proliferating normal cells (7) . Milner and Milner (8) reported that p53 is not synthesized in nondividing Go lymphocytes but is synthesized in the same lymphocytes when they are stimulated to proliferate by the addition of concanavalin A. Because p53 has been closely associated with cellular proliferation and transformation, it has been suggested that it is involved in the regulation ofthe mammalian cell cycle.
Several monoclonal antibodies have now been described that react with p53 of mouse cells by immunofluorescence and immunoprecipitation (5, 6, 9, 10 Antibodies. Two p53 monoclonal antibodies of mouse origin were used in these studies. One was a y2a product of hybridoma 200-47, described by Dippold et aL (9) , and the second was a y2b product ofhybridoma PAb 122, described by Gurney et aL (5) . Lyt-2.2 monoclonal antibody (aLyt-2.2) was a y2a product of hybridoma 19/178, originally derived by Ulrich Hammerling. aLyt-2.2 was used as a microinjection control, because expression of Lyt-2.2 is restricted to cells of T-cell lineage. The reactivity ofhamster antisera to the Mr 72,000 protein of adenovirus 2 (Ad2) has been described by Rossini et al (11) . Antisera having specificity for the SV40 T antigen were derived from hamsters bearing SV40 tumors (12) .
Immunoglobulin Preparations. Immunoglobulin fractions were prepared by ammonium sulfate precipitation of (i) sera from nu/nu mice bearing hybridoma 20047 (ap53) or hybridoma 19/178 (aLyt-2.2), (ii) supernatant fluid of cultures of hybridoma PAb 122 (ap53), or (iii) sera of hamsters bearing SV40-induced tumors (aSV40 T antigen). The precipitates obtained after the addition of 45% saturated ammonium sulfate were resuspended in phosphate-buffered saline and dialyzed extensively against the same buffer at 4°C prior to microinjection. In all cases, the concentration of microinjected protein was 2.5 mg/ml.
Microinjection Procedure. The microinjection procedure was carried out according to Graessmann and Graessmann (13) with slight modifications developed in our laboratory (12 
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 17 hr, for which labeling was for 0.5 hr. The first experiment was designed to determine whether the ap53 could inhibit serum-stimulated DNA synthesis during the prereplicative phase. The second experiment was designed to determine two things: first, whether ap53 could inhibit DNA synthesis when microinjected after the addition of serum-i.e., during the G1 phase-and second, whether ap53 microinjected at 17 hr after serum stimulation, when most cells were in S phase, could inhibit ongoing DNA synthesis.
The results given in Table 1 indicate that (i) microinjection of aLyt-2.2 has no effect whatsoever on serum-stimulated DNA synthesis or ongoing DNA synthesis in Swiss 3T3 cells and (ii) ap53 clearly inhibits serum-stimulated DNA synthesis when it is microinjected at, or around, the time of stimulation. When ap53 is microinjected 4 or 6 hr after serum stimulation, it has no inhibitory effect on serum-stimulated DNA synthesis. When microinjected when the cells are already in S phase, ap53 has no effect on ongoing DNA synthesis. These experiments were repeated four times. In all cases, when cells were microinjected with ap53 at 2 hr before to 2 hr after serum stimulation, inhibition of DNA synthesis was observed, although the degree of inhibition varied from one experiment to another. (12) . With regard to the SV40-transformed cell line, SV3T3, Table 3 (9) . However, at 32 hr after infection of quiescent 3T3 cells with SV40, both SV40 T antigen and p53 Swiss 3T3 cells were made quiescent and infected with SV40 at 100-500 plaque-forming units per cell or Ad2 at 500 plaque-forming units per cell and after 1 hr of adsorption the original plating medium containing 1% calf serum was added to the cells. At 0.5 hr after addition of the medium, the cells were microinjected with ap53 or aLyt- 
DISCUSSION
It has been reported that antibodies microinjected into cells preserve their specificity ofaction without apparent toxicity (12, (14) (15) (16) . Floros et aL (12) showed that preimmune IgG microinjected into the nuclei of quiescent 3T3 cells does not inhibit serum-stimulated DNA synthesis, whereas monoclonal antibody against the SV40 T antigen did specifically inhibit SV40-induced, but not serum-stimulated, DNA synthesis. These microinjected antibodies have a half-life ofapproximately 20 hr (14, 15) . Using this technique, we have now determined that monoclonal antibody directed against p53 effectively inhibits serum-induced DNA synthesis when it is microinjected into the nuclei of quiescent cells at or around the time of serum stimulation. This effect cannot be attributed to toxicity because ap53 has no effect on serum-stimulated DNA synthesis when it is microinjected 4 hr after serum stimulation, and monoclonal antibody to an unrelated antigen, Lyt-2.2, has no effect on DNA synthesis of Swiss 3T3 cells regardless of when it is microinjected into the nuclei. Furthermore, when antibody against RNA polymerase I is microinjected into the nuclei of quiescent cells, serum-stimulated DNA synthesis is not inhibited at all, although nucleolar RNA synthesis is inhibited for several hours (unpublished data). Our results therefore strongly support the possibility proposed by Milner and Milner (8) and Jay et aL (7) that p53 is involved in the regulation ofcell proliferation. These experiments, while not defining the role ofp53 in the initiation of cell proliferation, do suggest that p53 is a key factor in the transition of cells from a resting to a growing stage. As to the reason why the microinjected antibody is effective only between -2 and +2 hr of stimulation, three possibilities can be raised: (i) p53 is no longer needed after the first few hours after stimulation; (ii) the amount of p53 that accumulates by 4 hr is greater than the binding capacity ofmicroinjected ap53; or (iii) in view of the reported binding ofp53 to DNA (17) , bound p53 becomes inaccessible to antibody with time. Under similar experimental conditions, ap53 does not inhibit Ad2-or SV40-induced cell DNA synthesis. These results, particularly in the case of SV40, are surprising. However, because SV40 can overcome the block of Gl-specific temperature-sensitive mutants of the cell cycle (whereas serum stimulation cannot) (12) , it is possible that SV40 T antigen may induce cell DNA synthesis independently of p53.
Novi and Baserga (18) reported that a short inhibition ofprotein synthesis by cycloheximide, for 2 hr, when carried out very early after stimulation ofcell proliferation, completely inhibited the subsequent entry of cells into S phase. Similar doses of cyCell Biology: Mercer et al.
cloheximide were totally ineffective after the first few hours after stimulation. On the basis of these results, Novi and Baserga (18) speculated that a very labile gene product was made in the first 3-4 hr after stimulation and that if the synthesis of this product was inhibited, the whole process of stimulated DNA synthesis would come to a halt. This idea was reproposed in 1979 by Rossow et al. (19) and, more recently, by Pledger et al. (20) and Smith and Stiles (21) . We suggest that this labile gene product, which is necessary for stimulation of cell proliferation and has a very short half-life in the beginning of the prereplicative phase, is p53.
